Springer Nature [academic journals on nature.com], British Journal of Cancer, 3(126), p. 313-315, 2022
DOI: 10.1038/s41416-021-01646-w
Full text: Download
AbstractLiquid biopsy approaches are relatively well developed for cancer therapy monitoring and disease relapse, but they also have incredible potential in the cancer early detection and screening field. There are, however, several challenges to overcome before this potential can be met. Research in this area needs to be cohesive and, as a driver of research, Cancer Research UK is in an ideal position to enable this.